MSC-EXPRESSED IMMUNOMODULATORS IN COMBINATION WITH CAR-T FOR CANCER THERAPY

摘要

This technology describes novel cell based combined therapeutic modalities that induces mechanism based tumor cell killing in a broad spectrum of sensitive and resistant tumors. These new agents are tumor specific and target a broad spectrum of solid tumors.